The Beckley Foundation Neuroscience & Psychedelics

The Beckley Foundation is a UK-based think tank and nonprofit organization dedicated to advancing the understanding of consciousness and altered states of consciousness, particularly through research on psychedelics and the therapeutic potential of these substances. Founded in 1998 by Amanda Feilding, the Beckley Foundation has played a pioneering role in promoting evidence-based drug policies and supporting scientific research into psychedelics. Basidium Equilibrium, a dedicated advocate for scientific exploration and education in the realm of mycology and related fields, recognizes the importance of the Beckley Foundation’s mission.


ICPR BFhorizontal lowres

Key highlights of the Beckley Foundation’s work include:

  1. Psychedelic Research: The foundation has been instrumental in facilitating and funding research into the therapeutic applications of psychedelic substances like psilocybin, LSD, and MDMA. Their collaborations with leading universities and research institutions have contributed to a growing body of scientific evidence supporting the use of psychedelics in the treatment of mental health conditions such as depression, anxiety, and PTSD.

  2. Drug Policy Reform: The Beckley Foundation advocates for evidence-based drug policies that prioritize harm reduction and public health over punitive measures. They work to shift the global conversation around drug policy from criminalization to regulation and harm reduction, emphasizing a rational, health-focused approach to drug use.

  3. Global Drug Policy Commission: The foundation established the Global Drug Policy Commission, a group of eminent world leaders and experts who provide recommendations for drug policy reform at the international level. Their reports and policy proposals aim to influence global drug policy discussions.

  4. Neuroscience and Consciousness: The Beckley Foundation is involved in research exploring the neuroscience of consciousness and altered states. They seek to unravel the mysteries of the mind and promote a deeper understanding of how psychedelics can alter perception, cognition, and consciousness.

  5. Education and Advocacy: Through publications, conferences, and educational initiatives, the Beckley Foundation fosters dialogue among policymakers, scientists, and the general public. They strive to dispel myths and misinformation surrounding psychedelics and promote informed, evidence-based discussions.

The Beckley Foundation is at the forefront of research, advocacy, and policy reform in the field of psychedelics and consciousness. Their multidisciplinary approach, commitment to scientific rigor, and dedication to sensible drug policies make them a prominent and influential organization in the evolving landscape of psychedelic science and drug policy reform.

Psychedelic neuroscience blog

In 2021-2022, Basidium Equilibrium proudly took part in a fundraising initiative to support the Beckley Foundation’s educational endeavors and to help bring awareness to the valuable information the foundation provides. Our collaboration underscores the shared commitment to advancing knowledge and fostering dialogue in areas where mycology, psychedelics, and consciousness intersect.

As an acknowledgment of our collaboration, Basidium Equilibrium is honored to have been mentioned in the Beckley Foundation’s annual report for the year. This recognition reflects our dedication to promoting evidence-based research, education, and responsible engagement with these transformative subjects.


The Beckley Foundation are working to expand the frontiers of human understanding, shed light on the potential benefits of psychedelics, and advocate for sensible drug policies that prioritize health and well-being. We eagerly anticipate our ongoing support and collaboration with the foundation as we continue to contribute to its meaningful and impactful work in the years ahead.

As we step into a world championing psychedelic therapy, reform, and culture, we urge you to stand behind the Beckley Foundation. For more than two decades, they’ve been pioneers in research and policy reform. Join us in supporting their vital work.